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Background and aims
Gene therapy has strong therapeutic potential for the
personalized treatment of type 1 diabetes. Local gene
delivery methods for gene therapy are a promising strat-
egy to increase the therapeutic genes concentration at the
target location. Transient ultrasound can cause the local
increase of cell membrane permeability thus promoting
the penetration of transfection particles into the cell.
The objective
of this work is to evaluate transfection efficiency and
safety for intrahepatic polyplex-mediated gene delivery
by sonoporation.
Methods
Polyplexes of expression vector DNAs complexed to
galactose-bearing polyethylenimine (L-PEI) have been
used. Expression vectors are two plasmids containing
expression cassette for full-size human preproinsulin
gene controlled with CMV promoter and flanked by
inverted terminal repeats of AAV (pTRhins) and the
same cassette for marker gfp gene (pTRegfp). Animals
were injected under US guidance with polyplexes in a
dose of 40 µg pTRegfp /0.7 ml (rat) and of 15 µg
pTRhins /0.15 ml (diabetic mouse) into the liver par-
enchyma of subdiaphragmal segments using 31 G nee-
dles. Afterwards injection locus in depth of 1 cm during
180 sec was insonated by 130 Db ultrasound using mul-
tifrequency 3-5 MHz probe.
Results
Sonoporation is able to increase polyplex gene transfer
to liver cells in vivo. Flow cytometry analysis of primary
hepatocytes isolated from the liver of experimental rats
showed that ultrasound -enhanced polyplex gene trans-
fer was highly localized, and was superior to all controls.
At least 42% of the liver cells in vivo can be transfected
in this way with ultrasound exposure versus 1.2% with-
out it. Hypoglycemic effect of the insulin gene delivery
followed by 3 min US exposure was observed on the
third day: glucose level of diabetic mice (hyperglycemic
6- week) decreased in average by 30%. Nevertheless sono-
poration does not increase naked plasmid DNA (without
L-PEI ) transfection efficiency. A week and a month after
the procedure serial sections from rat liver injected with
polyplexes containing 40 µg marker plasmid or saline
solution alone exposed to US and without it was analyzed
for the presence of inflammation. Pathomorphological
and histological analysis of experimental livers revealed
no inflammatory processes in tissues, and any detectable
side effects of US-enhanced gene delivery were seen.
Experimental mice and rat liver DNAs were positive in
transgene PCR for 3 months after gene delivery.
Conclusions
Our results demonstrate that polyplex gene transfer by
US exposure is effective, robust and feasible and illus-
trate the potential of ultrasound-triggered gene delivery
technology for gene therapy.
Outlook and expert recommendations
As a follow-up to this study, it is recommended to cre-
ate project to study and implement diabetic gene ther-
apy with drug delivery systems for personalized
treatment of type 1 diabetes.
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